Delivery Order SPE2DB22D3102-SPE2DB25FL2PU
- Not listed
- The Defense Logistics Agency awarded a $1,751.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for ENGERIX-B 20 MCG/ML vaccine syringes. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an...
- The Defense Logistics Agency awarded a delivery order valued at $1,751.90 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $5,149.00 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML syringes, a hepatitis B vaccine product. This firm fixed-price delivery order, awarded on July 16, 2025, with an ultimate completion date of July 17, 2025, represents a competitively awarded, non-set-aside contract. The product will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a...
- The Defense Logistics Agency awarded a delivery order valued at $3,091.68 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes on July 15, 2025, with completion scheduled for July 16, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $3,027.09 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine product, with an ultimate completion date of September 15, 2025. The delivery order, issued on September 12, 2025, is a non-set-aside award executed under a competitive procurement process. AmerisourceBergen's Corporate Office, headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its primary location. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,751.90 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes on September 10, 2025, with completion scheduled for September 11, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $2,428.65 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes, with a completion date of July 30, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor that supplies a comprehensive...
- The Defense Logistics Agency awarded a $1,954.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes, with an ultimate completion date of August 21, 2025. This non-set-aside competitive award is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded a $30,338.25 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of ENGERIX-B 20 MCG/ML vaccine syringes. The contract, which is scheduled for completion by August 7, 2025, represents a non-set-aside competitive award and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes valued at $1,040.85 on June 5, 2025, with completion scheduled for June 6, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- SPE2DB22D3102Indefinite Delivery Contract
- SPE2DB22D3102-SPE2DB25FL2PUDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,334.40 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes under a firm fixed price contract. This non-set-aside award was made on August 14, 2025, with an ultimate completion date of August 15, 2025. The product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was competitively selected to fulfill this federal medical procurement requirement. The company's DLA Troop Support Medical contract serves as a primary vehicle for supplying vaccines, medications, medical devices, and specialized healthcare commodities to support military healthcare programs and other federal health systems worldwide, including the Defense Health Agency and U.S. Coast Guard. ENGERIX-B is a hepatitis B vaccine commonly utilized in military medical readiness programs and federal vaccination initiatives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 8/14/25 |